Archive - May 2018
WuXi Biologics to Invest $60 Million in New Singapore Biomanufacturing Facility
WuXi Biologics to Invest $60 Million in New Singapore Biomanufacturing Facility
Banned pregnancy drug linked to new cases of ADHD
The race to treat migraines heats up
New Right-to-Try Law Challenges FDA Oversight
New Right-to-Try Law Challenges FDA Oversight
Daily Brief: Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more
BioMarin ups the ante for pivotal haemophilia gene therapy trial